BioNTech stock falls in premarket trading after co-founders announce plans to launch a new mRNA venture by 2026.
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
BioNTech stock falls in premarket trading after co-founders announce plans to launch a new mRNA venture by 2026.